Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Acourx Pharmaceuticals is a publicly traded, clinical-stage biopharmaceutical company focused on developing a new class of antibiotics targeting infections from bacteria designated as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention, and Food and Drug Administration.